Skip to main content
. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3

Lee 2008

Methods RCT
enrolled: 48
evaluated: 48
Participants pathologically confirmed nonsmall cell lung cancer
clinically silent brain metastases (not surgically resectable)
age 18‐75 years
ECOG performance status 0‐3
adequate bone marrow, hepatic, renal functions
no prior chemotherapy nor molecular‐targeted therapy
Interventions chemotherapy first followed by whole brain radiation
versus
whole brain radiation followed by chemotherapy
Outcomes progression‐free survival
tumour response
quality of life
toxicity
Notes